This exec sold his start-up to big pharma. Now he has a bigger goal
by Sally Patten · Australian Financial ReviewSally PattenBOSS editor
Apr 9, 2026 – 5.00am
Manny Simons, the managing director of pharmaceuticals behemoth Eli Lilly in Australia and New Zealand, is something of a polymath.
He has an undergraduate degree in neuroscience and music from Harvard University and a PhD in biomedical engineering from Massachusetts Institute of Technology. He plays the piano, trumpet and guitar, sings early classical music and founded a start-up that he sold in 2022 to his current employer.
Loading...
Save
Log in or Subscribe to save article
Share
Copy link
Copied
Copy link
Copied
Share via...
Gift this article
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Already a subscriber? Login
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Read More
Sally PattenBOSS editorSally Patten edits BOSS, and writes about workplace issues. She was the financial services editor and personal finance editor of the AFR, The Age and the Sydney Morning Herald. She edited business news for The Times of London. Connect with Sally on Twitter. Email Sally at spatten@afr.com
Executive Education
Powered by
Latest In Leaders
Fetching latest articles